Clinical trial Recruiting at 1 site Interventional Ages 20 to 70

Exploring touch sensations to improve feedback in prosthetics

Official title: Studies Into Touch in Healthy Humans to Provide Sensory Feedback in Prostheses

Run by Institut National de la Santé Et de la Recherche Médicale, France · NCT05548322 · Data updated 2026-11-12

This study is testing how touch sensations can be improved in prosthetics to help amputees feel better and interact more naturally with their devices.

Quick facts

Study typeInterventional
Ages20 Years to 70 Years
SexAll
Enrollment210 (estimated)
SponsorInstitut National de la Santé Et de la Recherche Médicale, France
Government
Locations2 sites (Marseille and 1 other locations)
StatusRecruiting
StartedApril 15, 2024
Main results expectedOctober 2, 2034
Study endsNovember 2, 2034
Registry record updatedMarch 4, 2026
Trial IDNCT05548322 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include men and women aged 20 to 70, particularly those with unilateral upper or lower limb amputations lasting more than two years.

Probably not a fit

Patients with peripheral neuropathy, chronic pain, or those with a neurological or psychiatric history may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project investigates how mechanoreceptors in the human body respond to various external stimuli to enhance our understanding of the somatosensory system. By examining the fundamental firing patterns of these receptors, the study aims to develop better sensory feedback mechanisms for prosthetic devices. Participants will experience different surfaces, emotional state changes, and electrical stimulation to assess their responses. The ultimate goal is to recreate the lost sensory input in amputees, improving their interaction with prosthetics.

Why it matters

Potential benefit: If successful, this research could lead to more advanced prosthetic devices that provide realistic sensory feedback, significantly enhancing the quality of life for amputees.

How similar studies have gone: While there have been advancements in sensory feedback for prosthetics, this specific approach to understanding mechanoreceptor responses is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Men and women aged between 20 and 70.
* Be a member of a social security scheme, or a beneficiary of such a scheme
* Be calm enough to sit still for four hours.
* Specific for people participating in Arm 7 on amputees: People with an upper or lower limb amputation (unilateral) of more than 2 years.

Exclusion Criteria:

* Have peripheral neuropathy (diabetes, Raynaud's disease) or chronic muscle and/or sensory pain.
* Have a neurological or psychiatric history.
* Be subject to epilepsy.
* Be pregnant (declared) or breastfeeding, having given birth within the last year.
* Be afraid of injections.
* Being under dermatological treatment.
* Have a pacemaker.
* Not being able to understand the information leaflet and the consent form or sign it.
* Be subject to a legal protection measure (declarative)
* Be a protected adult (curatorship or guardianship)

Where it's running

  • CNRS - Aix-Marseille University UMR7291
    Marseille, France
    Recruiting
  • Hôpital HIA Lavéran
    Marseille, France
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.